Day One Biopharmaceuticals, Inc.
DAWN
$7.46
$0.497.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.32M | -36.00M | -65.71M | 37.04M | -4.41M |
| Total Depreciation and Amortization | 964.00K | 894.00K | 759.00K | 746.00K | 408.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.82M | 8.61M | 8.21M | 65.18M | -95.87M |
| Change in Net Operating Assets | -2.27M | -32.51M | 26.74M | -52.21M | 50.74M |
| Cash from Operations | -24.81M | -59.00M | -30.01M | 50.75M | -49.13M |
| Capital Expenditure | -3.00K | -317.00K | -1.42M | -724.00K | -26.00K |
| Sale of Property, Plant, and Equipment | 32.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.29M | -32.30M | -268.22M | -66.98M | 17.08M |
| Cash from Investing | 26.32M | -32.61M | -269.64M | -67.70M | 17.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 748.00K | -- | 1.85M | 179.15M | 1.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 20.94M | -- |
| Cash from Financing | 748.00K | -- | 1.85M | 200.10M | 1.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.26M | -91.61M | -297.80M | 183.15M | -30.78M |